<qa>  What is the name of the type of cancer that is relapsed after or intolerant2. Patients who are refractory to, relapsed after or intolerant to standard therapy, or for whom no standard therapy exists: i Advanced thyroid carcinoma -- Anaplastic thyroid carcinoma: Positive IHC for V600E or known history of BRAF mutation is allowed to enroll; Locoregional disease no longer amenable to curative surgery or radiation, or advanced disease with measurable primary or metastatic disease; Papillary thyroid carcinoma -- Must be beyond 3 weeks from last radioactive iodine treatment and AEs associated with previous therapy must be resolved to Grade 1 or baseline; Thyroid stimulating hormone TSH less than the upper limit of normal ULN per institutional laboratory ranges. ii Other advanced tumors eg. colorectal cancer, non-small cell lung cancer, cholangiocarcinoma. 